IDO1 and neoplasm: Recent and growing evidence describes the existence of an apo-form of IDO1 (namely, the protein without heme cofactor and thus catalytically inactive) in the tumor microenvironment that could contribute to the immunoregulatory milieu via its non-enzymatic activity (36–38).